Current Portfolio
Noema Pharma
Noema Pharma is committed to developing treatments for debilitating disorders of the central nervous system (CNS), conditions characterized by imbalanced neuronal networks leading to unresolved severe symptoms and significant impact on patients’ lives.
Key Facts
- Sector
Life Sciences
- Country
Switzerland
- Fund
LSP 7
- Entry
2024
Website

Do You Want to Know More?
We are eager to explore how we can achieve great things together.